EUVIMEDEUVIMED entdecken
Crossref

A real‐world Australian experience of upadacitinib for the treatment of severe atopic dermatitis

Vanessa Tran iD, Gayle Ross

Australasian Journal of Dermatology · 2023-11 · 64 (4)

DOI: 10.1111/ajd.14139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australasian Journal of Dermatology, online erschienen am 31.07.2023. Verfasst von Vanessa Tran und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Royal Melbourne Hospital, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Janus Kinase Inhibitors. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Upadacitinib is a selective Janus kinase‐1 (JAK‐1) inhibitor that has been shown in clinical trials to be effective for the treatment of moderate‐to‐severe atopic dermatitis (AD). This study aimed to evaluate the real‐world experience of patients with AD treated with upadacitinib in a single‐centre Australian cohort. Our study revealed a higher propensity for herpetic infections compared with previous randomised controlled trials (RCTs).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicJanus Kinase InhibitorsHumansAustraliaHeterocyclic Compounds, 3-RingTreatment Outcome

Stichwörter der Autor:innen

JAK-1 inhibitoratopic dermatitiseczemaherpes simplexherpes zosterreal-worldupadacitinib

Substanzen

upadacitinibHeterocyclic Compounds, 3-RingJanus Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Dermatology, Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.

ORCID-Profile: Vanessa Tran

Zitieren

APA

Tran, V., & Ross, G. (2023). A real‐world Australian experience of upadacitinib for the treatment of severe atopic dermatitis. Australasian Journal of Dermatology, 64(4). https://doi.org/10.1111/ajd.14139

Vancouver

Tran V, Ross G. A real‐world Australian experience of upadacitinib for the treatment of severe atopic dermatitis. Australasian Journal of Dermatology. 2023;64(4). doi:10.1111/ajd.14139

BibTeX
@article{Tran2023,
  author = {Tran, Vanessa and Ross, Gayle},
  title = {A real‐world Australian experience of upadacitinib for the treatment of severe atopic dermatitis},
  journal = {Australasian Journal of Dermatology},
  year = {2023},
  volume = {64},
  number = {4},
  doi = {10.1111/ajd.14139}
}
Kostenlos starten →